Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darryl Falzarano

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Antimicrobial Agents and Chemotherapy|June 15, 2022
Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into CellsSimoun Icho, Edurne Rujas, Krithika Muthuraman, et al.
Viruses|October 27, 2022
SARS-CoV-2 Variant-Specific Infectivity and Immune Profiles Are Detectable in a Humanized Lung Mouse ModelYunyun Di, Jocelyne Lew, Una Goncin, et al.
The Journal of Infectious Diseases|October 10, 2012
A Syrian golden hamster model recapitulating ebola hemorrhagic feverHideki Ebihara, Marko Zivcec, Donald Gardner, et al.
Antiviral Research|November 26, 2023
A phenothiazine urea derivative broadly inhibits coronavirus replication via viral protease inhibitionKatrina Forrestall, Eric S Pringle, Dane Sands, et al.
Plos Pathogens|October 23, 2013
Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structureMasfique Mehedi, Thomas Hoenen, Shelly Robertson, et al.
The Journal of Infectious Diseases|August 12, 2016
Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and MayingaAbhilash I Chiramel, Logan Banadyga, Jonathan D Dougherty, et al.
Viruses|June 28, 2023
Generation of a SARS-CoV-2 Reverse Genetics System and Novel Human Lung Cell Lines That Exhibit High Virus-Induced CytopathologyJuveriya Qamar Khan, Megha Rohamare, Karthic Rajamanickam, et al.
Scientific Reports|May 31, 2022
High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infectionAntonio Facciuolo, Erin Scruten, Sean Lipsit, et al.
Viruses|November 11, 2022
Feasibility of Polyclonal Avian Immunoglobulins (IgY) as Prophylaxis against Human Norovirus InfectionChad Artman, Nnebuefe Idegwu, Kyle D Brumfield, et al.
Viruses|January 28, 2026
Developing Synthetic Full-Length SARS-CoV-2 cDNAs and Reporter Viruses for High-Throughput Antiviral Drug ScreeningMegha Rohamare, Nidhi Kaushik, Juveriya Qamar Khan, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Antimicrobial Agents and Chemotherapy|June 15, 2022
Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into CellsSimoun Icho, Edurne Rujas, Krithika Muthuraman, et al.
Viruses|October 27, 2022
SARS-CoV-2 Variant-Specific Infectivity and Immune Profiles Are Detectable in a Humanized Lung Mouse ModelYunyun Di, Jocelyne Lew, Una Goncin, et al.
The Journal of Infectious Diseases|October 10, 2012
A Syrian golden hamster model recapitulating ebola hemorrhagic feverHideki Ebihara, Marko Zivcec, Donald Gardner, et al.
Antiviral Research|November 26, 2023
A phenothiazine urea derivative broadly inhibits coronavirus replication via viral protease inhibitionKatrina Forrestall, Eric S Pringle, Dane Sands, et al.
Plos Pathogens|October 23, 2013
Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structureMasfique Mehedi, Thomas Hoenen, Shelly Robertson, et al.
The Journal of Infectious Diseases|August 12, 2016
Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and MayingaAbhilash I Chiramel, Logan Banadyga, Jonathan D Dougherty, et al.
Viruses|June 28, 2023
Generation of a SARS-CoV-2 Reverse Genetics System and Novel Human Lung Cell Lines That Exhibit High Virus-Induced CytopathologyJuveriya Qamar Khan, Megha Rohamare, Karthic Rajamanickam, et al.
Scientific Reports|May 31, 2022
High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infectionAntonio Facciuolo, Erin Scruten, Sean Lipsit, et al.
Viruses|November 11, 2022
Feasibility of Polyclonal Avian Immunoglobulins (IgY) as Prophylaxis against Human Norovirus InfectionChad Artman, Nnebuefe Idegwu, Kyle D Brumfield, et al.
Viruses|January 28, 2026
Developing Synthetic Full-Length SARS-CoV-2 cDNAs and Reporter Viruses for High-Throughput Antiviral Drug ScreeningMegha Rohamare, Nidhi Kaushik, Juveriya Qamar Khan, et al.
Pageof 10